2020
Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters
Rank M, Sharaf R, Furuta G, Aceves S, Greenhawt M, Spergel J, Falck-Ytter Y, Dellon E, Institute A, Chachu K, Day L, Lebwohl B, Muniraj T, Patel A, Peery A, Shah R, Singh H, Singh S, Spechler S, Sultan S, Su G, Thrift A, Weiss J, Weizman A, collaborators J, Bernstein J, Dinakar C, Golden D, Khan D, Lieberman J, Oppenheimer J, Shaker M, Stukus D, Wallace D, Wang J. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology 2020, 158: 1789-1810.e15. PMID: 32359563, PMCID: PMC9473155, DOI: 10.1053/j.gastro.2020.02.039.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, TopicalAdultAdvisory CommitteesAge FactorsAllergy and ImmunologyChildDilatationEosinophilic EsophagitisEosinophilsEsophagoscopyEvidence-Based MedicineFood HypersensitivityFood, FormulatedGastroenterologyGlucocorticoidsHumansProton Pump InhibitorsSocieties, MedicalTreatment OutcomeUnited StatesConceptsShort-term treatment periodEsophageal eosinophil countsHigh-power fieldLow certaintyTopical glucocorticosteroidsModerate certaintyEosinophilic esophagitisEosinophil countTreatment periodPractice parametersAmerican Gastroenterological Association InstituteAnti-IgE therapyAnti-TNF therapyChronic inflammatory conditionsProton pump inhibitorsJoint Task ForceDiet eliminationDietary eliminationElimination dietEoE managementEsophageal eosinophiliaMaintenance therapyRecommendations AssessmentElemental dietEsophageal dilation
2017
Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group
Conwell DL, Banks PA, Sandhu BS, Sherman S, Al-Kaade S, Gardner TB, Anderson MA, Wilcox CM, Lewis MD, Muniraj T, Forsmark CE, Cote GA, Guda NM, Tian Y, Romagnuolo J, Wisniewski SR, Brand R, Gelrud A, Slivka A, Whitcomb DC, Yadav D. Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group. Digestive Diseases And Sciences 2017, 62: 2133-2140. PMID: 28600657, PMCID: PMC6040886, DOI: 10.1007/s10620-017-4621-z.Peer-Reviewed Original ResearchConceptsRisk factorsIdiopathic etiologyEpidemiologic trendsChronic pancreatitis patientsRecent epidemiologic trendsMultiple risk factorsCurrent epidemiologic trendsNAPS2 studyAlcohol etiologyCP patientsYounger patientsChronic pancreatitisCommon etiologyPancreatitis patientsMean ageConclusionOur dataUS CentersStudy groupEtiologyObjectivesOur aimPatientsGenetic etiologySmokingDemographic factorsValidation study
2012
Diabetes and pancreatic cancer.
Muniraj T, Chari ST. Diabetes and pancreatic cancer. Minerva Gastroenterology 2012, 58: 331-45. PMID: 23207610, PMCID: PMC3932318.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsBody Mass IndexClinical Trials as TopicDiabetes Mellitus, Type 2Early Detection of CancerEvidence-Based MedicineGlobal HealthGlucose IntoleranceHumansHyperinsulinismHypoglycemic AgentsInsulin GlargineInsulin, Long-ActingMeta-Analysis as TopicMetforminObesityPancreatic NeoplasmsPrevalenceRisk AssessmentRisk FactorsConceptsType 2 diabetesNew-onset diabetesPancreatic cancerPancreatic cancer-associated diabetesAnti-diabetic medicationsDuration of diseasePancreatic cancer patientsYears of ageGlucose toleranceCancer patientsOnset diabetesHigh riskEpidemiological studiesDiabetesCancerAdditional markersModest increaseRiskInverse relationshipRecent studiesMedicationsPatientsDisease